Searchable abstracts of presentations at key conferences in endocrinology

ea0099oc9.3 | Oral Communications 9: Pituitary and Neuroendocrinology | Part II | ECE2024

Loss of heterozygosity predicts treatment-refractory behavior in pituitary neuroendocrine tumors

Lin Andrew , Rudneva Vasilisa , Richards Allison , Zhang Yanming , Rosenblum Marc , Donoghue Mark , Tabar Viviane , Geer Eliza

Background: Pituitary neuroendocrine tumors (PitNETs) exhibiting treatment-refractory behavior are the rare subset that progress after radiation and are characterized by unrelenting growth and metastatic dissemination.Methods: To identify biomarkers of treatment-refractory behavior, two groups of patients with PitNETs were consented to matched tumor-normal whole exome and targeted next-generation DNA sequencing on a clinical protocol: a prospective group...